Urinary tract infection Urological and Genital Diseases Urinary tract infection
Conditions
Interventions
ShanStar® Cranberry extract 150mg and 300mg per day. Participants in each group are given pills - 3 months supply. Participants are instructed to take one tablet twice a day by mouth for 3 months. At
Sponsors
ShanStar Biotech, Inc.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Age between the age of 18-50 2. Female gender 3. Healthy individual with 3 or more episodes of urinary tract infections per year 4. Able to complete the research study
Exclusion criteria
Exclusion criteria: 1. Terminal diesease or dementia 2. Abstain from any cranberry, health food fruit extracts, anti-oxidants, vitamins, minerals and antibiotics for 2 weeks prior to participation in the study 3. Pregnancy 4. Urine catherisation within previous 2 weeks of study 5. Participants with history of diabetes, cardiovascular disease, symptoms of pyelonephritis and stones in the urinary tract 6. Sexually transmitted disease 7. Pyuria or bacteriuria on urinalysis or positive urine culture ( will be treated and wait 2 weeks to be eligible)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At 1, 2, and 3 months, the participants will return to answer urinary tract symptoms questions and provide urine for complete urialysis and culture. Primary outcome measures are: 1. Decrease in urinary tract infection symptoms score and decreased bacteriruia and pyuria and culture in urine study | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcome measures | — |
Countries
United States of America
Outcome results
None listed